In utero Hematopoietic Cell Transplantation: What Are the Important Questions?
- 5 December 2003
- journal article
- review article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 19 (1) , 9-12
- https://doi.org/10.1159/000074253
Abstract
The treatment of congenital hematologic disorders before birth by in utero hematopoietic stem cell transplantation remains a challenging goal. Although success has been achieved in X-linked severe combined immunodeficiency, the approach has failed in all other disorders attempted thus far. In this review, we examine relevant experimental data from the perspective of an analysis of why failure has occurred. We will also attempt to pose the important questions that will need to be answered prior to further clinical attempts to treat most target disorders by this approach.Keywords
This publication has 8 references indexed in Scilit:
- High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantationBlood, 2002
- Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusionBlood, 2002
- In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergyJournal of Pediatric Surgery, 1999
- Microchimerism and Tolerance afterin UteroBone Marrow Transplantation in MiceJournal of Surgical Research, 1998
- Treatment of X-Linked Severe Combined Immunodeficiency by in Utero Transplantation of Paternal Bone MarrowNew England Journal of Medicine, 1996
- Acquisition of immunologic self-toleranceCell, 1989
- Positive and negative selection of an antigen receptor on T cells in transgenic miceNature, 1988
- GENE CONTROL OF HEMATOPOIESISThe Journal of Experimental Medicine, 1969